Related Experiment Video
Updated: Sep 26, 2026

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses
Published on: August 30, 2018
A multi-agent system approach for monitoring the prescription of restricted use antibiotics
L Godo1, J Puyol-Gruart, J Sabater
1Artificial Intelligence Research Institute (IIIA), Spanish Council for Scientific Research (CSIC), Campus UAB, 08193 Bellaterra, Spain. godo@iiia.csic.es
Abstract:
Hospitals have a specified set of antibiotics for restricted use (ARU), very expensive, which are only recommended for special pathologies. The pharmacy department daily checks the prescription of this kind of antibiotics since it is often the case that, after a careful analysis, one can get the same therapeutic effects by using normal antibiotics which are much cheaper and usually less aggressive. In this paper, we describe a multi-agent system to help in the revision of medical prescriptions containing antibiotics of restricted use. The proposed approach attaches an agent to each patient which is responsible of checking different medical aspects related to his/her prescribed therapy. A pharmacy agent is responsible for analyzing it and suggesting alternative antibiotic treatments. All these agents are integrated in a hospital distributed scenario composed by many different kinds of software and human agents. This patient-centered multi-agent scenario is specified using the design methodology of Electronic Institutions.
Insights
This study introduces a multi-agent system to optimize hospital antibiotic use. The system helps pharmacists review restricted antibiotic prescriptions, suggesting cheaper, effective alternatives to reduce costs and improve patient care.
Area of Science:
- Medical Informatics
- Artificial Intelligence in Healthcare
- Pharmacoeconomics
Background:
- Hospitals utilize expensive antibiotics for restricted use (ARU) reserved for specific conditions.
- Pharmacy departments routinely review ARU prescriptions to identify opportunities for cost savings and reduced patient harm.
- Alternative, less aggressive, and more affordable antibiotics can often achieve similar therapeutic outcomes.
Purpose of the Study:
- To develop and describe a multi-agent system (MAS) for assisting in the review of medical prescriptions involving antibiotics of restricted use.
- To enhance the efficiency and accuracy of identifying cost-effective and therapeutically equivalent antibiotic alternatives.
- To integrate a patient-centered MAS within a distributed hospital information system.
Main Methods:
- A multi-agent system approach was designed, with individual agents assigned to each patient to monitor their therapy.
- A dedicated pharmacy agent analyzes patient-specific data and prescribed ARU to suggest alternative treatments.
- The system architecture was specified using the Electronic Institutions design methodology within a distributed hospital environment.
Main Results:
- The proposed MAS facilitates the systematic review of restricted antibiotic prescriptions.
- The system enables the identification of potential substitutions with cheaper and less aggressive antibiotic options.
- The patient-centered agent design allows for personalized therapy assessment within a complex hospital IT infrastructure.
Conclusions:
- The developed multi-agent system offers a valuable tool for hospital pharmacies to optimize the use of restricted antibiotics.
- Implementing this system can lead to significant cost reductions and improved patient safety by promoting the use of appropriate and affordable treatments.
- The Electronic Institutions framework provides a robust method for specifying complex, distributed agent-based systems in healthcare settings.
Related Concept Videos
Pharmaceutical Poisoning: Potential Scenarios
Prescription, Nonprescription and Orphan Drugs
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Mechanism of Antibiotic Resistance in MRSA
Clinical Significance of Antibiotic Resistance
Combined Effects of Drugs: Synergism
Such synergistic combinations...

